Used in pharmaceutical research as an intermediate for synthesizing bioactive molecules, particularly in the development of kinase inhibitors such as tyrosine kinase inhibitors for cancer treatment. Its structure supports binding to enzyme active sites, making it valuable in creating potential anticancer and anti-inflammatory agents. The compound's halogenated indolinone core, featuring iodine and fluorine groups, enhances metabolic stability and target selectivity in drug design, and is suitable for development as radiolabels or markers in medical imaging techniques like PET scans. Also employed in medicinal chemistry for structure-activity relationship (SAR) studies due to its modifiable scaffold.